Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 890 results found since Jan 2013.
American Stroke Association, Feb. 9-11
The annual International Stroke Conference of the American Heart Association/American Stroke Association was held from Feb. 9 to 11 in New Orleans and attracted participants from around the world, including cerebrovascular research and practice...
Source: Drugs.com - Pharma News - February 22, 2022 Category: Pharmaceuticals Source Type: news
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
TUESDAY, Feb. 22, 2022 -- Among patients with a history of ischemic stroke, more intensive low-density lipoprotein cholesterol (LDL-C)-lowering statin-based therapies are associated with a decreased risk for recurrent stroke but an increased risk...
Source: Drugs.com - Pharma News - February 22, 2022 Category: Pharmaceuticals Source Type: news
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
FRIDAY, Feb. 18, 2022 -- About half of patients with COVID-19 with acute ischemic stroke (AIS) have poor outcomes, with 38.8 percent mortality, according to a study recently published in the Journal of Neurology, Neurosurgery& Psychiatry.
Adam...
Source: Drugs.com - Pharma News - February 18, 2022 Category: Pharmaceuticals Source Type: news
Bridging Therapy May Be Better for Large Vessel Occlusion Stroke
FRIDAY, Feb. 18, 2022 -- For patients with anterior circulation large vessel occlusion (LVO) stroke, use of intravenous thrombolysis followed by mechanical thrombectomy (MT; also known as bridging therapy [BT]) is associated with increased odds of...
Source: Drugs.com - Pharma News - February 18, 2022 Category: Pharmaceuticals Source Type: news
Physical Activity in Early Late Life May Cut Risk for CVD
FRIDAY, Feb. 18, 2022 -- A higher level of physical activity among the elderly is associated with a lower risk for incident cardiovascular diseases, but not stroke, especially early in late life, according to a study published online Feb. 16 in...
Source: Drugs.com - Pharma News - February 18, 2022 Category: Pharmaceuticals Source Type: news
ASA: Endovascular Therapy Studied in Large Ischemic Stroke
THURSDAY, Feb. 16, 2022 -- Patients with large cerebral vessel occlusion and sizable strokes on imaging have better functional outcomes at 90 days, but more intracranial hemorrhages, with endovascular therapy plus medical care versus medical care...
Source: Drugs.com - Pharma News - February 17, 2022 Category: Pharmaceuticals Source Type: news
New ERLEADA ® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
SAN FRANCISCO, Feb. 14, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA® (apalutamide) results in high rates of rapid and deep prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC). In a separate post-hoc analysis of the registrational Phase 3 SPARTAN and TITAN studies, rapid and deep PSA responses with ERLEADA® were associated with improvement in patient-reported outcomes (PROs) related to quality of life, physical wellbeing, pain, and fatigue intensity. The...
Source: Johnson and Johnson - February 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Study Finds Increased Heart Disease, Stroke Risk After Surviving Even Mild Covid-19
Overall, those who had recovered from Covid-19 coronavirus infections were 63% more likely to have had some kind of cardiovascular problem in the ensuing year.
Source: Forbes.com Healthcare News - February 13, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
Time to Benefit Estimated for Intensive BP Control to Prevent Stroke
WEDNESDAY, Feb. 9, 2022 -- About 1.7 years of more intensive hypertensive treatment would be needed to prevent one stroke per 200 older adults, according to research published online Feb. 9 in the Journal of the American Geriatrics Society.
Vanessa...
Source: Drugs.com - Pharma News - February 9, 2022 Category: Pharmaceuticals Source Type: news
ASA: BP Telemonitoring Aids Stroke Survivors in Underserved Areas
TUESDAY, Feb. 8, 2022 -- Remote blood pressure monitoring and telehealth visits improve outcomes for stroke survivors who live in historically under-resourced communities, according to a study presented at the American Stroke Association...
Source: Drugs.com - Pharma News - February 8, 2022 Category: Pharmaceuticals Source Type: news
ASA: Scoring System May Predict Stroke Risk in COVID-19 Inpatients
TUESDAY, Feb. 8, 2022 -- A new scoring system helps predict the risk for stroke among adults hospitalized with COVID-19, according to a study presented at the American Stroke Association International Stroke Conference, held from Feb. 9 to 11 in New...
Source: Drugs.com - Pharma News - February 8, 2022 Category: Pharmaceuticals Source Type: news
ASA: Less Bleeding Seen With Tenecteplase for Ischemic Stroke
FRIDAY, Feb. 4, 2022 -- For patients with ischemic stroke, use of tenecteplase (TNK) for thrombolysis is associated with a lower rate of symptomatic intracranial hemorrhage (sICH) than alteplase (ALT), according to a study presented at the American...
Source: Drugs.com - Pharma News - February 4, 2022 Category: Pharmaceuticals Source Type: news
ASA: Myocardial Infarction May Hasten Cognitive Decline in Adults
THURSDAY, Feb. 3, 2022 -- Significantly faster declines in global cognition, memory, and executive function are seen following incident myocardial infarction (MI), according to a study presented at the American Stroke Association International...
Source: Drugs.com - Pharma News - February 3, 2022 Category: Pharmaceuticals Source Type: news
ASA: Stroke Rates Down in Elderly, Up in Young Adults in the U.S.
THURSDAY, Feb. 3, 2022 -- Although age-standardized stroke burden measures decreased or remained stable from 1990 to 2019 in the United States, the incidence of stroke is increasing among young adults in the South and Midwest, according to a study...
Source: Drugs.com - Pharma News - February 3, 2022 Category: Pharmaceuticals Source Type: news
Janssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers
Raritan, NJ, Feb. 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 17 presentations will be featured at the 2022 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place in San Francisco and virtually from February 17-19. Building on its long-term leadership in prostate cancer, Janssen is committed to advancing innovative treatments and transforming patient experiences, while focusing on research that may drive better outcomes for people across the genitourinary cancer spectrum. Data to be presented include Phase 3 results for the selective ...
Source: Johnson and Johnson - February 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
